Cargando…

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy

Current anatomic TNM stage classification fails to capture the immune heterogeneity of oral squamous cell carcinoma (OSCC). Increasing evidence indicates the strong association between epithelial-mesenchymal transition (EMT) and tumor immune response. In this study, we employed an EMT signature to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Si-yuan, Ren, Xian-yue, Wang, Chun-yang, Chen, Xi-juan, Cao, Ruo-yan, Liu, Qin, Pan, Xue, Zhou, Jia-ying, Zhang, Wei-lin, Tang, Xin-Ran, Cheng, Bin, Wu, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281347/ https://www.ncbi.nlm.nih.gov/pubmed/34277389 http://dx.doi.org/10.3389/fonc.2021.587862

Ejemplares similares

4sc‐202 and Ink‐128 cooperate to reverse the epithelial to mesenchymal transition in OSCC
por: Yang, Xi, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
por: Wang, Guangyu, et al.
Publicado: (2021)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

Construction and validation of a novel signature based on epithelial-mesenchymal transition–related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment
por: Gao, Biao, et al.
Publicado: (2022)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
por: Zhou, Yang, et al.
Publicado: (2022)

Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis
por: Xu, Huiyong, et al.
Publicado: (2021)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

Landscape and kinetic path quantify critical transitions in epithelial-mesenchymal transition
por: Lang, Jintong, et al.
Publicado: (2021)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response
por: Liu, Dong, et al.
Publicado: (2023)

Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer
por: Opławski, Marcin, et al.
Publicado: (2021)

Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
por: Khadri, Fatima-Zohra, et al.
Publicado: (2021)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
por: Feng, Shengyu, et al.
Publicado: (2022)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
por: Zhang, Yanlong, et al.
Publicado: (2023)

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma
por: Yu, Ting-Ting, et al.
Publicado: (2018)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma
por: Song, Kewei, et al.
Publicado: (2022)

Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
por: Ai, Jun, et al.
Publicado: (2023)

Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
por: Zhang, Zizhen, et al.
Publicado: (2020)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
por: Soundararajan, Rama, et al.
Publicado: (2019)

The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer
por: Voutsadakis, Ioannis A
Publicado: (2015)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition
por: Qiu, Yushan, et al.
Publicado: (2023)

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients
por: Huang, Xiao-Yong, et al.
Publicado: (2014)

miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
por: Zhang, Hong-Yu, et al.
Publicado: (2020)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

Transcriptome Landscape of Epithelial to Mesenchymal Transition of Human Stem Cell–Derived RPE
por: Sripathi, Srinivasa R., et al.
Publicado: (2021)

Hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis
por: Xie, Shang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6927mo8i2bqvmiht9js36v6qsg